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T
he fields of blood banking (BB) and transfusion
medicine (TM), like other areas of medicine,
have evolved into specialties with a diverse array
of areas of knowledge. These areas include
advances in the detection of pathogens in donated blood,
advances in methods to collect and manipulate progeni-
tor cells, advances in blood conservation techniques, and
advances in treatments for both the acutely and the
chronically ill patient, among many others. As a conse-
quence, the knowledge base that a resident trainee in
pathology is expected to master has expanded well
beyond the mere understanding of compatibility testing
and inventory management.
In the past several years, guidance regarding pathol-
ogy residency training has been published for clinical
pathology and anatomic pathology, as well as in some
subspecialty areas.1-8 Although intended for medical stu-
dents, an NIH-funded transfusion medicine curriculum
initiative also provided a comprehensive overview of areas
of knowledge relevant to pathology resident training.9,10 A
survey of TM fellowships was also performed with impli-
cations for residency training, as have recent commentar-
ies regarding the role of physicians in blood centers and
hospital transfusion services.11-13 There is no document
that specifically addresses pathology residency training in
BB and/or TM, however, and the current requirements of
the Accreditation Council for Graduate Medical Education
(ACGME) on general competencies in residency training.14
Recently, the Academy of Clinical Laboratory Physicians
and Scientists (ACLPS) and the members of the Children’s
Health Initiative through Laboratory Diagnostics
(CHILDx) separately produced comprehensive clinical
pathology residency training documents of which BB
and/or TM was a subsection.3,8 As a follow-up to the activi-
ties of ACLPS and the new requirements of the ACGME
regarding general competencies, a task force was created
by the AABB to address the needs for a residency curricu-
lum on this subject. The rotation objectives outlined
below for BB and TM were adapted from the subsection on
BB and/or TM from the ACLPS document and further
expanded. The task force further elaborated on these
objectives by including additional guidance on the differ-
ent needs of the general anatomic pathology– and clinical
pathology–trained pathologist, who has either minimal or
infrequent supervision of a transfusion service, compared
with the specialist whose responsibilities might include
directing a blood collection center, a cell therapeutics
laboratory, or a high-complexity transfusion service. The
task force further designated what each specific rotation
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objective accomplished with respect to the ACGME
general competencies.
In addition to the provision and further elaboration of
a common set of rotation objectives to help residency pro-
grams ensure adequate depth and breadth of training in
BB and/or TM, three particular areas were also considered
by the task force: skill levels, duration of rotation, and
need for time at other facilities when local training
resources are limited.
SKILL LEVELS
The skill levels of the rotation objectives are roughly
divided into three categories:
• Skill Level 1: Expectation of all clinical pathology resi-
dents after their initial months of training.
• Skill Level 2: Expectation of all clinical pathology resi-
dents by completion of residency training.
• Skill Level 3: Expectation for all BB and TM fellows
and all other trainees who assume comparable job
responsibilities afterward (e.g., hematology-oncology
fellows or clinical pathology–only trainees desiring to
direct a high complexity transfusion service and/or
blood bank at an academic medical center).
The distribution of objectives between the different
skill levels is intended as a rough guideline for the progres-
sion of a resident’s acquisition of skills, knowledge, and
experience in TM and/or BB. It is the task force’s belief,
however, that the sum of objectives in Skill Levels 1 and 2
are reasonable expectations of a resident by completion of
residency training. Individual training programs vary in
the length and intensity of BB and/or TM rotations and
the volume and frequency of clinical material. Therefore,
there will be some differences in the sequence in which
some of these objectives are expected to be accomplished
within each program. In addition, the resident’s progres-
sion through the different areas and skill levels will vary
according to individual abilities and interest. Finally,
where some objectives overlap at the different skill levels,
the expectation is that the resident will exercise greater
independence with skills already previously acquired.
DURATION OF ROTATION AND NEED FOR
TIME SPENT AT OTHER FACILITIES
The ACGME has no requirements for the minimum
number of months required for any particular area of
pathology training, although it does have requirements for
the number of cases reviewed in other areas of pathology
training.15 Furthermore, some residency programs include
some aspects of hemostasis and/or coagulation testing or
histocompatibility testing as part of their BB and/or TM
rotation, whereas for other residency programs these are
separate rotations.Therefore, an accounting of the number
of months that a resident should devote to BB and/or TM is
difficult in actual practice. The minimum requirements
have ranged from as few as 2 months to as many as
5 months. The length of the overall exposure to BB and/or
TM should vary according to the goals of the particular
trainee and also based on the intensity of the local training
environment. Highly complex cases might arise frequently
in certain institutions, whereas other institutions may rely
more heavily on case studies and formal didactic
approaches to achieve the same goals. Some aspects of BB
and TM training, however, can only be obtained from
caring for patients or donors with special needs. In those
instances where certain rotation objectives cannot be
achieved with local resources, some thought should be
given to making arrangements with another facility to at
least provide some brief hands-on experience, particularly
at Skill Level III (e.g., regional blood center, tertiary
medical center, testing laboratories, apheresis service,
hematopoietic stem cell [HSC] transplant unit).
Finally, two areas outside of TM should be mentioned
because they are often incorporated into TM and/or BB
rotations in part or in whole: histocompatibility testing and
hemostasis and/or coagulation. Some resident rotation
objectives in hemostasis and/or coagulation are included
in this document.This is an acknowledgment that the areas
of hemostasis and/or coagulation cross the boundaries of
hematology, hematopathology, and TM. Depending on the
nature of the expertise in a particular institution, the phy-
sician trained in TM may render services in the diagnosis
and management of disorders of hemostasis and coagula-
tion. Likewise, histocompatibility testing also interfaces
with and has common origins with TM, and some histo-
compatibility testing objectives are included as they relate
directly to TM. More detailed objectives and goals for resi-
dent training in histocompatibility testing and in hemosta-
sis and/or coagulation can be found elsewhere.3 The task
force hopes that this document will be useful for residents,
fellows, and residency directors and those actively involved
in the teaching of TM and/or BB.
RECOMMENDED TRANSFUSION
MEDICINE AND/OR BLOOD BANKING
ROTATION OBJECTIVES
ACGME general competencies fulfilled by these objectives
are labeled as: professionalism [PR], patient care [PC],
medical knowledge [MK], practice-based learning and
improvement [PL], interpersonal and communication
skills [IC], and systems-based practice [SP].
Transfusion Service
Skill Level I
• Demonstrate knowledge of the principles of patient
and/or unit identification and pretransfusion testing,
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including ABO and/or Rh testing, red blood cell (RBC)
antibody screen, and antibody identification [PC,
MK].
• Choose appropriate crossmatching methods for
various patients (e.g., electronic, immediate-spin,
antiglobulin) [PC, MK].
• Recognize and appropriately refer serologic evalua-
tions that are beyond the scope of a hospital-based
transfusion service and/or blood bank [PC, SP].
• Describe the expected response to transfusion
therapy in adult and pediatric patients [MK, PC].
• Triage and screen requests for blood components
appropriately during inventory shortages [PC, SP].
• Demonstrate the ability to perform blood utilization
reviews [PC, SP].
• Demonstrate the ability to clinically evaluate a
reported transfusion reaction and order and
interpret appropriate initial laboratory testing [PC,
MK, PL].
• Recognize the symptoms and signs of hemolytic and
nonhemolytic transfusion reactions and demonstrate
knowledge of the pathophysiology, treatment, and
prevention of these complications [MK, PC].
• Identify the major infectious complications of blood
transfusions and the current risk of these infections
and explain how these infections can be prevented
[MK].
• Identify the major noninfectious complications of
blood transfusions, including TRALI, the risk of these
complications, and strategies to prevent them [MK].
• Demonstrate knowledge of the indications for
cytomegalovirus-reduced-risk blood, leukoreduc-
tion, irradiation, and washing of blood components
[MK].
• Choose appropriate blood components and deriva-
tives based on a thorough knowledge of the indica-
tions for transfusion [PL, PC, MK].
• Demonstrate knowledge of the pathophysiology,
prevention, and treatment of hemolytic disease of
the fetus and newborn. Recognize those antibodies
in pregnant patients that are clinically significant and
make appropriate recommendations for blood prod-
ucts [MK, PL, PC].
• Demonstrate knowledge of the potential side effects
of neonatal whole-blood exchanges and massive
transfusions in neonates associated with extracorpo-
real circuits such as used in extracorporeal mem-
brane oxygenation or in cardiac surgery [MK, PC].
• Demonstrate knowledge of the pathophysiology and
treatment of neonatal alloimmune thrombocytope-
nia [MK, PC].
• Demonstrate proficiency in the evaluation and
appropriate transfusion therapy of adult and pediat-
ric thrombocytopenic patients secondary to both
immune and nonimmune etiologies [PC, PL].
• Apply the principles of a massive transfusion protocol
[PL, IC, SP, MK].
• Demonstrate a working knowledge of the principles
of hemostasis and coagulation and proficiency in the
initial treatment of patients with bleeding disorders
[MK, PC].
• Demonstrate knowledge of the transfusion require-
ments of special patient populations (e.g.,
hematology-oncology, pediatrics, geriatrics, trans-
plantation, burn, and/or trauma) [MK, PC].
Skill Level II
• Demonstrate knowledge of options for preventing
volume overload in pediatric transfusion therapy
[MK, PC, SP].
• Identify clinically significant RBC-specific antibodies
from an antibody panel, determine how difficult it
will be to obtain blood for this patient, and effectively
communicate these results to clinicians [PC, IC].
• Demonstrate ability to distinguish clinically signifi-
cant from clinically insignificant RBC-specific anti-
bodies [MK].
• Demonstrate proficiency in evaluating and recom-
mending treatment plans for complex transfusion
reactions [MK, IC, SP, PC].
• Demonstrate familiarity with the requirements of all
applicable regulatory and accrediting agencies (e.g.,
JCAHO, CAP, AABB, FDA, FACT) [SP].
• Demonstrate competence in managing blood inven-
tory and ability to communicate effectively the hos-
pital’s needs to the blood supplier [IC, SP].
• Demonstrate knowledge of various methods of blood
conservation, including pre- and perioperative
autologous blood collection, and approaches to
“bloodless” surgery [MK, PL, SP].
• Demonstrate proficiency in evaluating patients
refractory to platelet (PLT) transfusions, including the
principles of histocompatibility testing and the roles
of HLA-matched PLTs versus PLT crossmatching, and
apply this knowledge in selecting appropriate PLT
products when indicated [PC, MK].
• Demonstrate proficiency in evaluating patients
with immune-mediated and non–immune-mediated
hemolytic anemia and in the appropriate testing and
transfusion management of these patients [PC, MK].
• Demonstrate ability to communicate laboratory
testing results, transfusion recommendations, and
blood supply issues to clinicians, both verbally and in
written form [IC, SP, PC].
• Demonstrate ability to write an appropriate consult
note for a patient who has an alloantibody, explaining
the clinical significance of the finding to the treating
physicians and the additional logistical requirements
for obtaining compatible blood [IC, SP, PC].
FUNG ET AL.
1932 TRANSFUSION Volume 47, October 2007
• Demonstrate knowledge of landmark published
studies in TM [MK, PL].
• Demonstrate proficiency in evaluating and present-
ing findings to professional colleagues from 1) recent
peer-reviewed journal articles related to TM and 2)
research projects in which the resident may partici-
pate [PL, IC].
• Demonstrate knowledge of how to host an inspection
by a regulatory or accrediting agency [SP, IC, PR].
• Demonstrate proficiency at preparing educational
presentations on TM topics and the ability to adapt
presentations to audiences of differing experience
levels (e.g., pathologists, nonpathology physicians,
technologists, nurses, and blood center workers) [IC,
MK].
• Differentiate between plasma-derived and recombi-
nant factor products and demonstrate knowledge of
on-label and off-label indications for these products
[PC, MK, PL, SP].
Skill Level III
• Demonstrate ability to interpret difficult antibody
panels including those containing multiple alloanti-
bodies, autoantibodies, and antibodies to high-
frequency antigens [MK, PC].
• Demonstrate knowledge of specialized test methods
in immunohematology including elution, absorption,
and use of enzymes [MK].
• Demonstrate familiarity with the appropriate use of
highly specialized blood products (e.g., granulocytes,
donor lymphocyte infusions, HLA-matched PLTs,
coagulation factor concentrates) [MK, PC].
• Demonstrate ability to select appropriate factor
replacement product(s) including creating an appro-
priate dose-time schedule for a patient through col-
laborative discussion with the patient’s primary team
physician [PC, MK, IC].
• Compare and contrast the various methods of per-
forming blood utilization review, including prospec-
tive versus retrospective review, and the role of peer
review as required by JCAHO and AABB standards [SP,
PL, IC].
• Demonstrate ability to perform lookback investiga-
tions [SP, IC].
• Demonstrate ability to write an error or deviation
report and create a corrective and preventive action
plan [IC, PL, SP].
• Demonstrate an understanding of the appropriate-
ness of transfusion of serologically incompatible
blood in selected clinical circumstances [PC, MK].
• Demonstrate familiarity with the scientific, legal, and
ethical issues surrounding allocation of resources,
cost containment, and the role of gatekeeper [PL, IC,
PR, SP].
• Demonstrate familiarity with ethical issues in BB and
TM (e.g., confidentiality as it relates to the blood
donor or patient, HIV testing and reporting, a
patient’s right to refuse blood transfusion, the use of
hematopoietic growth factors in normal donors, and
informed consent) [PR, PC].
• Demonstrate knowledge of the basic principles of
blood conservation and bloodless medicine and
surgery programs, including specific methods of pre-
serving RBC mass, supporting hemostasis, and
adjunctive therapies that may be used when the
oxygen supplied by the patient’s hemoglobin is insuf-
ficient [MK, SP, PL].
• Demonstrate familiarity with the relevant regional
plan for major disasters and explain the roles of the
local blood supplier and the transfusion service or
blood bank in this plan [SP, IC].
• Participate in an accreditation inspection of a labora-
tory related to TM and/or BB (this may be either an
official inspection or an unofficial and/or interim
inspection) [SP, PR, IC].
• Demonstrate familiarity with the requirements for
proper storage, preparation, and traceability of
tissue-derived grafts received and dispensed by the
transfusion service or blood bank [MK, SP, PC].
Blood collection, blood center, and cell processing
responsibilities
Skill Level I
• Demonstrate knowledge of current eligibility criteria
for blood donors [MK].
• Compare and contrast the eligibility requirements for
allogeneic and autologous blood donations [MK].
• Observe and subsequently demonstrate competency
in performing a donor interview and exam, including
obtaining consent to donate (e.g., risks, benefits,
alternatives, and answer questions) [PC, IC, PR].
• Demonstrate knowledge of the indications for thera-
peutic phlebotomy [MK].
• Demonstrate proficiency in evaluating and treating
adverse reactions associated with blood donation
and/or phlebotomy (both whole-blood and apheresis
donations) [PC, PR, MK].
• Outline the assay principles (e.g., nucleic acid testing,
enzyme-linked immunorbent assay) of required
donor blood tests and the associated confirmatory
testing and describe examples of donor reentry algo-
rithms [MK, SP].
• Demonstrate professionalism in interactions with
prospective donors [PR, IC].
• Demonstrate familiarity with the steps in blood
component and blood derivative preparation [MK,
SP].
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• Describe the factors that influence the motivation of
blood donors [MK, SP].
• Demonstrate knowledge of the advantages and disad-
vantages of directed blood donation and limited
donor exposure programs [PC, MK, SP].
• Demonstrate knowledge of the techniques of safe,
sterile venipuncture and the associated methods to
reduce bacterial contamination of products [PC, MK].
• Demonstrate familiarity with the types and treatment
of donor adverse events [PC, MK].
Skill Level II
• Outline the necessary steps in donor notification and
counseling associated with positive infectious disease
testing results and the donor lookback process [PC,
SP, IC].
• Demonstrate understanding of, and the ability to
interpret, the major regulations and guidelines appli-
cable to collection, processing, storage, and release of
blood products and cellular therapy products [SP,
MK].
• Demonstrate awareness of current concerns about
emerging infections in the blood supply and describe
ways that blood collection centers deal with these
concerns [MK, PL].
• Demonstrate familiarity with the operational logis-
tics required to determine appropriate blood inven-
tory for a geographic region and the process of
meeting daily, weekly, and monthly collection goals
[SP, IC].
• Demonstrate knowledge of the principles of HSC
transplantation, including collection, processing,
and storage of these products, and the indications
for use (e.g., marrow, peripheral blood, and placental
and/or umbilical cord blood) [MK, SP, PC].
• Demonstrate proficiency in writing physician orders
for peripheral blood HSC collections and obtaining
consent for the procedure and for blood product
transfusion, if needed after the collection [PC, MK,
IC, PR].
• Demonstrate proficiency in evaluating and treating
adverse reactions associated with peripheral blood
progenitor cell (PBPC) collection [PC, MK].
Skill Level III
• Demonstrate ability to review quality control data
from the collecting, processing, and storage of indi-
vidual HSC products and actions needed when
product or processing irregularities are identified
[MK, SP, PC].
• Demonstrate familiarity with emerging areas of cellu-
lar therapy, including hematopoietic graft engineer-
ing and cellular immunotherapeutics [MK, PL, PC].
• Demonstrate understanding of the elements of
current good manufacturing practices and current
good tissue practices as they apply to the collection,
processing, ex vivo manipulation, and storage of all
cellular therapy products (e.g., pancreatic islet cells,
negative and/or positive selection and/or purging of
HSCs, gene manipulation, donor lymphocyte infu-
sions, dendritic cell vaccines, ex vivo expansion of
progenitor cells) [MK, SP, PC].
• Demonstrate familiarity with requirements and pro-
cedures for source plasma donors [MK, SP, PC].
• Demonstrate familiarity with standards and regula-
tions that apply to blood collection centers, clinical
tissue banks, and PBPC processing laboratories (FDA,
AABB, FACT, CAP) [MK, SP, PC].
• Demonstrate familiarity with quality systems as they
apply to blood collection centers and PBPC process-
ing laboratories (i.e., AABB Quality System Essentials,
ISO 9000, lean manufacturing, Six Sigma) [SP, PL]
• Participate in quality review of the manufacturing or
processing of products [PL].
Therapeutic apheresis
Skill Level I
• Summarize the principles of apheresis technology,
including centrifugation, filtration, and immunoad-
sorption [MK].
• Demonstrate knowledge of the major indications for
therapeutic apheresis including the category of evi-
dence for each of these indications as outlined by
AABB and/or American Society for Apheresis [MK,
PC].
• Demonstrate knowledge of the appropriate replace-
ment fluids to be used in an apheresis procedure [MK,
PC].
• Demonstrate knowledge of vascular access require-
ments and options for therapeutic apheresis [MK,
PC].
• Demonstrate proficiency in evaluating and preparing
patients for therapeutic apheresis, including obtain-
ing consent for the procedure and for transfusion of
blood products during the procedure [IC, PC, PR].
• Communicate effectively with attending clinicians
and house staff regarding emergent or scheduled
therapeutic apheresis procedures through con-
versations and writing of consult notes [IC, SP, PR,
MK].
Skill Level II
• Discuss the major indications for, and limitations of,
therapeutic apheresis in children [PC, MK].
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• Demonstrate ability to triage requests for therapeutic
apheresis [MK, PC, IC, PR].
• Demonstrate proficiency in evaluating and treating
adverse reactions associated with therapeutic apher-
esis [PC, MK, IC].
• Write appropriate physician orders for therapeutic
apheresis procedures [PC, MK, IC].
Skill Level III
• Demonstrate proficiency in treating patients with
specialized apheresis methods (e.g., photopheresis,
immunoadsorption columns) [PC, MK].
• Demonstrate proficiency in evaluating, assessing,
and treating a wide variety of patients who require
therapeutic apheresis for various disorders [MK, PC,
IC, PR].
• Demonstrate ability to evaluate literature for thera-
peutic apheresis for which the data suggesting effi-
cacy for a particular disease entity is limited and
communicate effectively with primary care physi-
cians to develop a plan of care [MK, PC, IC, SP, PL].
TRANSFUSION MEDICINE REFERENCE
MATERIALS
Handbooks or introductory texts
Harmening DM. Modern blood banking and transfusion
practices. 5th ed. Philadelphia; F.A. Davis Co.; 2005.
Gottschall J, editor. Blood transfusion therapy: a phy-
sician’s handbook. 8th ed. Bethesda: American Associa-
tion of Blood Banks; 2005.
McLeod B, editor. Therapeutic apheresis: a physi-
cian’s handbook. 1st ed. Bethesda: American Association
of Blood Banks; 2005.
Roseff S, editor. Pediatric transfusion: a physician’s
handbook. 1st ed. Bethesda: American Association of
Blood Banks; 2003.
Snyder E, Haley NR. Cellular therapy: a physician’s
handbook. 1st ed. Bethesda: American Association of
Blood Banks; 2004.
McCullough J. Transfusion medicine. 2nd ed. New
York: Churchill Livingstone; 2004.
Petrides M, Stack G. Practical guide to transfusion
medicine. Bethesda: American Association of Blood
Banks; 2001
Murphy M, Pamphilon D, editors. Practical transfu-
sion medicine. 2nd ed. Boston: Blackwell Publishing;
2005.
Standards, comprehensive, or special topic texts
AABB Technical Manual. 15th ed. Bethesda: American
Association of Blood Banks; 2005.
Mintz PD. Transfusion therapy: clinical principles and
practice. 2nd ed. Bethesda: American Association of Blood
Banks; 2005.
Standards for blood banks and transfusion services.
24th ed. Bethesda: American Association of Blood Banks;
2006.
Standards for cellular therapy product services. 2nd
ed. Bethesda: American Association of Blood Banks; 2007.
McLeod BC, Price TH, Weinstein RA. Apheresis: prin-
ciples and practice. 2nd ed. Bethesda: American Associa-
tion of Blood Banks; 2003.
Hillyer CD, Silberstein LE, Ness PM, Anderson KC,
Roback JD. Blood banking and transfusion medicine:
basic principles and practice. 2nd ed. New York: Churchill
Livingstone; 2007.
Klein HG, Anstee, DJ. Mollison’s blood transfusion in
clinical medicine. 11th ed. Boston: Blackwell; 2005.
Simon TL, Dzik WH, Snyder EL, Rossi EC, Stowell
CP, Strauss RG. Rossi’s principles of transfusion medi-
cine. 3rd ed. Philadelphia: Lippincott Williams & Wilkins;
2002.
Petz LD, Garratty G. Immune hemolytic anemias. 2nd
ed. New York: Churchill Livingstone; 2004
Reid ME, Lomas-Francis C. The blood group antigen
facts book. 2nd ed. New York: Elsevier; 2004
Blackall DP, Helekar PS, Triulzi DJ. Transfusion
medicine: self-assessment and review. Bethesda: Ameri-
can Association of Blood Banks; 2002
Herman J, Manno C. Pediatric transfusion therapy.
Bethesda: American Association of Blood Banks; 2002
Hillyer CD, Strauss R, Luban N. Handbook of pediatric
transfusion medicine. San Diego: Elsevier Academic Press;
2004
Popovsky M, editor. Transfusion reactions. 3rd ed.
Bethesda: American Association of Blood Banks; 2007.
Spiess BD, Spence, RK, Shander A. Perioperative
transfusion medicine. 2nd ed. Philadelphia: Lippincott,
Williams, & Wilkins; 2005.
Issitt PD, Anstee DJ. Applied blood group serology. 4th
ed. Durham (NC): Montgomery Scientific; 1998
Web sites
http://www.aabb.org/content—Accrediting organization
for transfusion services, blood centers, and cell pro-
cessing laboratories. Includes links to several useful
resources.
http://www.fda.gov/cber/blood.htm—FDA/CBER
Web page with links to other documents on regulatory
issues pertaining to the production and use of blood
products.
http://www.osha.gov/SLTC/
bloodbornepathogens/—OSHA Web page with general
information on blood-borne pathogens, needle-stick pre-
vention, and blood exposure in the workplace.
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Accreditation of Cellular Therapy Web site.
http://www.cbbsweb.org/—California Blood Bank
Society Web site.
http://www.sabm.org/—Society for the Advance-
ment of Blood Management Web site.
http://www.nataonline.com—Network for Advance-
ment of Transfusion Alternatives Web site.
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